Edition:
United Kingdom

Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

115.97USD
19 Jun 2018
Change (% chg)

$-0.59 (-0.51%)
Prev Close
$116.56
Open
$115.68
Day's High
$116.36
Day's Low
$114.71
Volume
115,785
Avg. Vol
97,445
52-wk High
$119.03
52-wk Low
$94.58

Chart for

About

Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its... (more)

Overall

Beta: 0.93
Market Cap(Mil.): $5,230.56
Shares Outstanding(Mil.): 47.59
Dividend: --
Yield (%): --

Financials

  CRL.N Industry Sector
P/E (TTM): 29.01 84.11 32.75
EPS (TTM): 3.79 -- --
ROI: 7.94 1.56 14.38
ROE: 20.38 2.43 16.07

BRIEF-Charles River Laboratories Announces First-Quarter 2018 Results From Continuing Operations

May 10 Charles River Laboratories International Inc:

10 May 2018

BRIEF-Charles River Laboratories Reports Q1 Non-GAAP Earnings Per Share Of $1.38

May 10 Charles River Laboratories International Inc:

10 May 2018

BRIEF-Charles River Laboratories CEO's 2017 Total Compensation Was $12.6 Mln

March 29 Charles River Laboratories International Inc:

29 Mar 2018

BRIEF-Charles River Laboratories Announces Offering Of $500 Mln Of Senior Notes

March 26 Charles River Laboratories International Inc:

26 Mar 2018

BRIEF-Charles River Laboratories Q4 GAAP Loss Per Share $0.63

Feb 13 Charles River Laboratories International Inc:

13 Feb 2018

BRIEF-Charles River Laboratories International Board Size Increases From Ten To Eleven​

Jan 16 Charles River Laboratories International Inc:

16 Jan 2018

BRIEF-Charles River Laboratories Acquires KWS Biotest for GBP 15 Mln

Jan 11 Charles River Laboratories International Inc:

11 Jan 2018

Earnings vs. Estimates